Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Letter"
topic_facet:"Antibodies, Monoclonal"
format_facet:"Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Letter%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%22&lookfor=%221468-2060%22&type=ISN
PubPharm (157)
1
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Landon-Cardinal, O.
|
Allard-Chamard, H.
|
Chapdelaine, H.
| +3
Wird geladen...
2
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13 : the weight of nocebo effect
enthalten in:
Annals of the rheumatic diseases
| 2020
von
Germain, V.
|
Scherlinger, M.
|
Barnetche, T.
| +2
Wird geladen...
3
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Delyon, J.
|
Brunet-Possenti, F.
|
Leonard-Louis, S.
| +6
Wird geladen...
4
Response to : 'Comment on: 'Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al' by Isenberg
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Morand, E.
|
Trasieva, T.
|
Berglind, A.
| +2
CommentOn: Ann Rheum Dis. 2018 May;77(5):706-713. - PMID 29420200
Wird geladen...
5
Comment on : 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand et al
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Isenberg, D.
CommentOn: Ann Rheum Dis. 2018 May;77(5):706-713. - PMID 29420200
Wird geladen...
6
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Mammen, A.
|
Rajan, A.
|
Pak, K.
| +9
Wird geladen...
7
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?
enthalten in:
Annals of the rheumatic diseases
| 2019
von
Matos da Cunha, B.
CommentOn: Ann Rheum Dis. 2018 Jun;77(6):890-897. - PMID 29550766
Wird geladen...
8
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis
enthalten in:
Annals of the rheumatic diseases
| 2016
von
Ciccia, F.
|
Rizzo, A.
|
Guggino, G.
| +3
Wird geladen...
9
Response to : 'Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRA main and extension studies: utility of laboratory methods description' by Francesca Meacci et al
enthalten in:
Annals of the rheumatic diseases
| 2016
von
Braun, J.
CommentOn: Ann Rheum Dis. 2016 Oct;75(10):e62. - PMID 27401744
Wird geladen...
10
Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRAS main and extension studies : utility of laboratory methods description
enthalten in:
Annals of the rheumatic diseases
| 2016
von
Meacci, F.
|
Manfredi, M.
|
Infantino, M.
| +2
CommentIn: Ann Rheum Dis. 2016 Oct;75(10):e63. - PMID 27469978
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Letter
Filter aufheben
Thema: Antibodies, Monoclonal
Filter aufheben
Medienart: Aufsätze
Medienart
Aufsätze
82
E-Artikel
82
E-Ressourcen
75
Gedruckte Aufsätze
Zeitschriftentitel
157
Annals of the rheumatic diseases
Thema
Antibodies, Monoclonal
Letter
109
Antirheumatic Agents
82
B72HH48FLU
82
Infliximab
69
Case Reports
57
Tumor Necrosis Factor-alpha
33
Antibodies, Monoclonal, Humanized
30
4F4X42SYQ6
30
Antibodies, Monoclonal, Murine-Derived
30
Rituximab
28
Research Support, Non-U.S. Gov't
25
Comment
18
Immunosuppressive Agents
17
Adalimumab
17
FYS6T7F842
16
Immunoglobulin G
15
Etanercept
15
OP401G7OJC
15
Receptors, Tumor Necrosis Factor
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2020-
49
2010-2019
106
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
157
Englisch
Haven't found what you're looking for?
Wird geladen...